
|Videos|August 2, 2022
Available Genomic Tests for Clinically Localized Prostate Cancer
Author(s)Stephen J. Freedland, MD
A review of the currently available genomic testing options for patients with clinically localized prostate cancer and the NCCN and AUA/ASTRO recommendations based on risk group.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement












